ESC 365 - Safety, acute efficacy, and long-term clinical outcomes using the second-generation cryoballoon for pulmonary vein isolation in patients with pulmonary vein abnormality

EHRA Premium Access

Safety, acute efficacy, and long-term clinical outcomes using the second-generation cryoballoon for pulmonary vein isolation in patients with pulmonary vein abnormality

Session: Poster session 3 - Atrial fibrillation ablation - Cryoballoon

Topic: Rhythm Control, Catheter Ablation

Speaker: Doctor K. Yalin (Istanbul, TR)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Doctor Kivanc Yalin

Istanbul University Cerrahpasa, Istanbul (Türkiye)

0 follower

11 more presentations in this session

Is the cryoablation an effective treatment for paroxysmal AF patients with structural heart disease? Clinical outcomes from multicenter observational project

Speaker: Doctor G. Perego (Milan, IT)

Starting atrial fibrillation ablation program: a comparison between second generation cryoballoon and contact force sensing radiofrequency catheters

Speaker: Associate Professor V. Velagic (Zagreb, HR)

The second generation cryoballoon ablation is safe and useful for paroxysmal atrial fibrillation in super-elderly patients over 80 years: a report from two high-volume centers

Speaker: Doctor T. Yoshizawa (Kyoto, JP)

Frequency of phrenic nerve injury following cryo balloon and radio frequency ablations: a systematic review

Safety and efficacy of repeat cryoablation after index RF ablation: insight from a multicentric observational data collection.

Speaker: Professor C. Tondo (Monzino, IT)

Access the full session

Poster session 3 - Atrial fibrillation ablation - Cryoballoon

Speakers: Doctor K. Yalin, Doctor G. Perego, Associate Professor V. Velagic, Doctor T. Yoshizawa, Professor C. Tondo

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources